Allgaier v. Microbiologics, Inc.

CourtDistrict Court, D. Maryland
DecidedApril 7, 2023
Docket1:22-cv-01900
StatusUnknown

This text of Allgaier v. Microbiologics, Inc. (Allgaier v. Microbiologics, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Allgaier v. Microbiologics, Inc., (D. Md. 2023).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MARYLAND

BARBARA ALLGAIER, Plaintiff,

v. Civil No. 1:22-cv-01900-ELH

MICROBIOLOGICS, INC., Defendant.

MEMORANDUM OPINION Plaintiff Barbara Allgaier was employed by Microbiologics, Inc. (“Microbiologics”) as an “Area Sales Manager.” ECF 1, ¶ 4. Her employment began in September 2010, and she was terminated on September 18, 2019. Id. ¶¶ 6, 30.1 This employment discrimination suit followed on August 2, 2022. ECF 1 (the “Complaint”). The Complaint contains two counts. In particular, Count I asserts a claim of discrimination under Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C. § 2000e et seq. (“Title VII”), and Count II asserts a violation of the Maryland Wage Payment and Collection Law (“MWPCL”), Md. Code (2016 Repl. Vol., 2022 Supp.), §§ 3-501 et seq. of the Labor and Employment Article (“L.E.”). Plaintiff seeks compensatory, punitive, and treble damages, as well as attorney’s fees and costs. ECF 1, ¶¶ 51-54. Microbiologics has moved to dismiss the Complaint, pursuant to Fed. R. Civ. P. 12(b)(6). ECF 5. The motion is supported by a memorandum. ECF 5-1 (collectively, the “Motion”). Plaintiff opposes the Motion (ECF 8, the “Opposition), supported by two exhibits. ECF 8-1; ECF 8-2. In

1 The Complaint is unclear as to the exact date on which plaintiff’s employment began, and also unclear as to how long she served as an Area Sales Manager. ECF 1, ¶¶ 6, 7. Moreover, plaintiff does not describe the nature of defendant’s business or the kind of items that she sold. the Opposition, she complains, inter alia, that the Motion was untimely filed, and asks the Court to strike it on this basis. Defendant has replied, and urges the Court to strike the Opposition as untimely. ECF 9 (the “Reply”). No hearing is necessary to resolve the Motion. See Local Rule 105.6. For the reasons that follow, I shall grant the Motion in part and deny it in part, with leave to amend.

I. Factual and Procedural Background2 Plaintiff commenced employment with Microbiologics in September 2010. ECF 1, ¶ 6. During plaintiff’s tenure with Microbiologics, she was “an exemplary and high performing employee.” Id. ¶ 8. Throughout nine years of employment, Allgaier “never received a disciplinary reprimand or action.” Id. ¶ 21. Moreover, she received numerous awards and accolades, including the “‘President’s Award’ for sales,” id. ¶ 10; the “‘Top Sales Representative Award,’” id. ¶ 11; and the “Molecular Business Growth Award.” Id. ¶ 12; see id. ¶ 9. Further, Allgaier’s “name is listed twice on the Microbiologics High Honor Plaque” at company headquarters. Id. ¶ 13. At the time of Allgaier’s discharge, she was the only employee whose name was listed on the High Honor

Plaque. Id. ¶ 14. At the time of Allgaier’s termination, she was working as an Area Sales Manager, and her “direct supervisor” was Alan Kaplan. Id. ¶¶ 7, 15. Kaplan served as Microbiologics’s “vice president of sales for North America.” Id. ¶ 16. Notably, in August 2019, Kaplan distributed a

2 As discussed, infra, at this juncture I must assume the truth of the facts alleged in the suit. See Fusaro v. Cogan, 930 F.3d 241, 248 (4th Cir. 2019). Throughout the Memorandum Opinion, the Court cites to the electronic pagination. However, the electronic pagination does not always correspond to the page number imprinted on the particular submission. “United States Sales Force Rankings.” ECF 1, ¶ 17. Allgaier was ranked as the “number one area sales manager for North America. . . .” Id. In August 2019, Kaplan “sent an email to all the Sales Area Managers requesting dates for meetings in order to complete the individual’s third quarterly reviews.” Id. ¶ 22. Allgaier’s review

was originally scheduled for October 2, 2019. Id. ¶ 23. In a conference call on September 3, 2019, Allgaier asked Kaplan “why he wanted to meet with her” and Kaplan told her that “‘everything will be fine.’” Id. ¶ 24. During the conference call, Kaplan and Allgaier agreed to meet to complete the review on September 18, 2019. Id. ¶ 25. Kaplan “assured” Allgaier that defendant was “not intending to cut or eliminate any positions or territories,” id. ¶ 26, and that he ”intended to visit a client with the Plaintiff.” Id. ¶ 27. Allgaier met with Kaplan on September 18, 2019, at a hotel in Virginia. Id. ¶ 28. Tonya Inselman, Microbiologics’s Employee Engagement Manager, who served in the Human Resources department, was also in attendance. Id. ¶ 28. At the meeting, id. ¶ 29, Inselman informed Allgaier that she was being discharged due to “‘territory elimination.’” Id. ¶¶ 30, 31.

At the time of Allgaier’s discharge, she was defendant’s “only female area sales manager.” Id. ¶ 40. After Allgaier was terminated, Microbiologics’s “U.S. Area Sales Team consisted of all males.” Id. ¶ 42. Microbiologics had “terminated the other two female area sales managers in 2018 and 2019 respectively.” Id. ¶ 41. Moreover, at that time, “there were open sales and marketing positions outside of Plaintiff’s territory under Mr. Kaplan’s supervisory authority.” Id. ¶ 32. But, Allgaier was not offered “the opportunity” to be considered for any “position within the company.” Id. ¶ 33. After plaintiff’s discharge, Microbiologics continued to do business with entities within Allgaier’s former territory. Id. ¶ 35. According to plaintiff, her “district was not eliminated but redistributed.” ECF 1, ¶ 34. Specifically, plaintiff asserts that her clients and her district were “redistributed” to Mike Anderson and Joe Iacono, two of Allgier’s male counterparts. Id. ¶ 36. Anderson had been hired in March 2017 “to take over parts of Plaintiff’s New England territory that Plaintiff had grown too large to manage single handedly.” Id. ¶ 37. Plaintiff asserts

that Anderson was ranked “the lowest among sales managers” in the August 2019 employee ranking. Id. ¶ 38. Further, plaintiff claims that Iacono was also ranked lower than Allgaier in that same ranking. Id. ¶ 39. As of the time of plaintiff’s discharge, she had “booked approximately one-hundred- thousand dollars” in sales. Id. ¶ 18. The products were shipped after Allgaier’s departure. Id. ¶ 19. Allgaier alleges that she is “entitled” to commissions on these sales. Id. ¶ 20. But, she complains that Microbiologics has failed to pay the commissions. Id. ¶ 43. II. Standards of Review A defendant may test the legal sufficiency of a complaint by way of a motion to dismiss under Fed. R. Civ. P. 12(b)(6). Nadendla v. WakeMed, 24 F.4th 299, 304-05 (4th Cir. 2022); ACA

Fin. Guar. Corp. v. City of Buena Vista, 917 F.3d 206, 211 (4th Cir. 2019); Paradise Wire & Cable Defined Benefit Pension Plan v. Weil, 918 F.3d 312, 317 (4th Cir. 2019); In re Birmingham, 846 F.3d 88, 92 (4th Cir. 2017); Goines v. Valley Cmty. Servs. Bd., 822 F.3d 159, 165-66 (4th Cir. 2016); McBurney v. Cuccinelli, 616 F.3d 393, 408 (4th Cir. 2010), aff’d sub nom. McBurney v. Young, 569 U.S. 221 (2013); Edwards v. City of Goldsboro, 178 F.3d 231, 243 (4th Cir. 1999). A Rule 12(b)(6) motion constitutes an assertion by a defendant that, even if the facts alleged by a plaintiff are true, the complaint fails as a matter of law “to state a claim upon which relief can be granted.” Fed. R. Civ. P. 12(b)(6). Whether a complaint states a claim for relief is assessed by reference to the pleading requirements of Fed. R. Civ. P.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Meritor Savings Bank, FSB v. Vinson
477 U.S. 57 (Supreme Court, 1986)
Papasan v. Allain
478 U.S. 265 (Supreme Court, 1986)
Patterson v. McLean Credit Union
491 U.S. 164 (Supreme Court, 1989)
O'CONNOR v. Consolidated Coin Caterers Corp.
517 U.S. 308 (Supreme Court, 1996)
Swierkiewicz v. Sorema N. A.
534 U.S. 506 (Supreme Court, 2002)
Tellabs, Inc. v. Makor Issues & Rights, Ltd.
551 U.S. 308 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
McBurney v. Cuccinelli
616 F.3d 393 (Fourth Circuit, 2010)
Coleman v. Maryland Court of Appeals
626 F.3d 187 (Fourth Circuit, 2010)
Glassman v. Arlington County, VA
628 F.3d 140 (Fourth Circuit, 2010)
Bonds v. Leavitt
629 F.3d 369 (Fourth Circuit, 2011)
Katyle v. Penn National Gaming, Inc.
637 F.3d 462 (Fourth Circuit, 2011)
A Society Without a Name v. Commonwealth of Virginia
655 F.3d 342 (Fourth Circuit, 2011)
Denise Burgess v. Stuart Bowen, Jr.
466 F. App'x 272 (Fourth Circuit, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Allgaier v. Microbiologics, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/allgaier-v-microbiologics-inc-mdd-2023.